Protagonist Therapeutics, Inc.
PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES
Last updated:
Abstract:
The present invention provides novel peptide inhibitors of the interleukin-23 receptor, and related compositions and methods of using these peptide inhibitors to treat or prevent a variety of diseases and disorders, including inflammatory bowel diseases.
Status:
Application
Type:
Utility
Filling date:
7 May 2021
Issue date:
10 Feb 2022